Nitric oxide-induced regulatory T cells inhibit Th17 but not Th1 cell differentiation and function

Journal of Immunology

Volumn 191, Issue 1, 2013, Pages 164-170

  Niedbala, Wanda ^a   Besnard, Anne Gaelle ^a   Jiang, Hui R ^a,b   Alves Filho, Jose C ^a,c   Fukada, Sandra Y ^a,c   Nascimento, Daniela ^a,c   Mitani, Akio ^a,d   Pushparaj, Peter ^a,e   Alqahtani, Mohammed H ^e   Liew, Foo Y ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d AICHI GAKUIN UNIVERSITY   (Japan)

^e KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; NITRIC OXIDE; RETINOID RELATED ORPHAN RECEPTOR GAMMA; TRANSCRIPTION FACTOR T BET;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; IN VIVO STUDY; LYMPH NODE; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; TH1 CELL; TH17 CELL;

ANIMALS; CELL COMMUNICATION; CELL DIFFERENTIATION; CELLS, CULTURED; FEMALE; GROWTH INHIBITORS; IMMUNE TOLERANCE; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE; PRIMARY CELL CULTURE; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH17 CELLS;

EID: 84879665008     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202580     Document Type: Article

References (35)

1. Moncada, S., and A. Higgs. 1993. The L-arginine-nitric oxide pathway. N. Engl. J. Med. 329: 2002-2012. (Pubitemid 24015045)
2. Nathan, C., and Q. W. Xie. 1994. Nitric oxide synthases: roles, tolls, and controls. Cell 78: 915-918. (Pubitemid 24292319)
3. Liew, F. Y. 1995. Regulation of lymphocyte functions by nitric oxide. Curr. Opin. Immunol. 7: 396-399.
4. Kim, Y. M., H. T. Chung, R. L. Simmons, and T. R. Billiar. 2000. Cellular nonheme iron content is a determinant of nitric oxide-mediated apoptosis, necrosis, and caspase inhibition. J. Biol. Chem. 275: 10954-10961.
5. Macphail, S. E., C. A. Gibney, B. M. Brooks, C. G. Booth, B. F. Flanagan, and J. W. Coleman. 2003. Nitric oxide regulation of human peripheral blood mononuclear cells: critical time dependence and selectivity for cytokine versus chemokine expression. J. Immunol. 171: 4809-4815. (Pubitemid 37310601)
6. Lukic, M. L., S. Stosic-Grujicic, N. Ostojic, W. L. Chan, and F. Y. Liew. 1991. Inhibition of nitric oxide generation affects the induction of diabetes by streptozocin in mice. Biochem. Biophys. Res. Commun. 178: 913-920.
7. McInnes, I. B., B. P. Leung, M. Field, X. Q. Wei, F. P. Huang, R. D. Sturrock, A. Kinninmonth, J. Weidner, R. Mumford, and F. Y. Liew. 1996. Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients. J. Exp. Med. 184: 1519-1524. (Pubitemid 26354707)
8. Smith, K. J., and H. Lassmann. 2002. The role of nitric oxide in multiple sclerosis. Lancet Neurol. 1: 232-241. (Pubitemid 37159185)
9. Rios-Santos, F., J. C. Alves-Filho, F. O. Souto, F. Spiller, A. Freitas, C. M. Lotufo, M. B. Soares, R. R. Dos Santos, M. M. Teixeira, and F. Q. Cunha. 2007. Down-regulation of CXCR2 on neutrophils in severe sepsis is mediated by inducible nitric oxide synthase-derived nitric oxide. Am. J. Respir. Crit. Care Med. 175: 490-497. (Pubitemid 46354253)
10. Nagy, G., J. M. Clark, E. I. Buzás, C. L. Gorman, and A. P. Cope. 2007. Nitric oxide, chronic inflammation and autoimmunity. Immunol. Lett. 111: 1-5. (Pubitemid 47017476)
11. Niedbala, W., X. Q. Wei, C. Campbell, D. Thomson, M. Komai-Koma, and F. Y. Liew. 2002. Nitric oxide preferentially induces type 1 T cell differentiation by selectively up-regulating IL-12 receptor β2 expression via cGMP. Proc. Natl. Acad. Sci. USA 99: 16186-16191. (Pubitemid 35462770)
12. +CD25 T cells via p53, IL-2, and OX40. Proc. Natl. Acad. Sci. USA 104: 15478-15483.
13. Niedbala, W., J. C. Alves-Filho, S. Y. Fukada, S. M. Vieira, A. Mitani, F. Sonego, A. Mirchandani, D. C. Nascimento, F. Q. Cunha, and F. Y. Liew. 2011. Regulation of type 17 helper T-cell function by nitric oxide during inflammation. Proc. Natl. Acad. Sci. USA 108: 9220-9225.
14. Murphy, C. A., C. L. Langrish, Y. Chen, W. Blumenschein, T. McClanahan, R. A. Kastelein, J. D. Sedgwick, and D. J. Cua. 2003. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med. 198: 1951-1957. (Pubitemid 38032126)
15. Langrish, C. L., Y. Chen, W. M. Blumenschein, J. Mattson, B. Basham, J. D. Sedgwick, T. McClanahan, R. A. Kastelein, and D. J. Cua. 2005. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201: 233-240. (Pubitemid 40189432)
16. Ahern, P. P., A. Izcue, K. J. Maloy, and F. Powrie. 2008. The interleukin-23 axis in intestinal inflammation. Immunol. Rev. 226: 147-159.
17. Miossec, P., T. Korn, and V. K. Kuchroo. 2009. Interleukin-17 and type 17 helper T cells. N. Engl. J. Med. 361: 888-898.
18. Keefer, L. K., R. W. Nims, K. M. Davies, and D. A. Wink. 1996. "NONOates" (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms. Methods Enzymol. 268: 281-293.
19. Ivanov, I. I., B. S. McKenzie, L. Zhou, C. E. Tadokoro, A. Lepelley, J. J. Lafaille, D. J. Cua, and D. R. Littman. 2006. The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126: 1121-1133. (Pubitemid 44380299)
20. + regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192: 303-310.
21. Asseman, C., S. Mauze, M. W. Leach, R. L. Coffman, and F. Powrie. 1999. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 190: 995-1004.
22. Park, H., Z. Li, X. O. Yang, S. H. Chang, R. Nurieva, Y. H. Wang, Y. Wang, L. Hood, Z. Zhu, Q. Tian, and C. Dong. 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6: 1133-1141. (Pubitemid 41541791)
23. Steinman, L. 2008. A rush to judgment on Th17. J. Exp. Med. 205: 1517-1522. (Pubitemid 351962013)
24. Weiner, H. L. 2008. A shift from adaptive to innate immunity: a potential mechanism of disease progression in multiple sclerosis. J. Neurol. 255(Suppl. 1): 3-11. (Pubitemid 351341867)
25. - precursors. J. Immunol. 169: 4183-4189.
26. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198: 1875-1886.
27. Walker, M. R., D. J. Kasprowicz, V. H. Gersuk, A. Benard, M. Van Landeghen, J. H. Buckner, and S. F. Ziegler. 2003. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25-T cells. J. Clin. Invest. 112: 1437-1443. (Pubitemid 38057697)
28. Stock, P., O. Akbari, G. Berry, G. J. Freeman, R. H. Dekruyff, and D. T. Umetsu. 2004. Induction of T helper type 1-like regulatory cells that express Foxp3 and protect against airway hyper-reactivity. Nat. Immunol. 5: 1149-1156. (Pubitemid 39549629)
29. Vieira, P. L., J. R. Christensen, S. Minaee, E. J. O'Neill, F. J. Barrat, A. Boonstra, T. Barthlott, B. Stockinger, D. C. Wraith, and A. O'Garra. 2004. IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+regulatory T cells. J. Immunol. 172: 5986-5993. (Pubitemid 38621199)
30. Fukaura, H., S. C. Kent, M. J. Pietrusewicz, S. J. Khoury, H. L. Weiner, and D. A. Hafler. 1996. Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-β1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. J. Clin. Invest. 98: 70-77. (Pubitemid 26243822)
31. Laurence, A., C. M. Tato, T. S. Davidson, Y. Kanno, Z. Chen, Z. Yao, R. B. Blank, F. Meylan, R. Siegel, L. Hennighausen, et al. 2007. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 26: 371-381. (Pubitemid 46413906)
32. Littman, D. R., and A. Y. Rudensky. 2010. Th17 and regulatory T cells in mediating and restraining inflammation. Cell 140: 845-858.
33. Lukacs-Kornek, V., D. Malhotra, A. L. Fletcher, S. E. Acton, K. G. Elpek, P. Tayalia, A. R. Collier, and S. J. Turley. 2011. Regulated release of nitric oxide by nonhematopoietic stroma controls expansion of the activated T cell pool in lymph nodes. Nat. Immunol. 12: 1096-1104.
34. O'Connor, R. A., C. T. Prendergast, C. A. Sabatos, C. W. Lau, M. D. Leech, D. C. Wraith, and S. M. Anderton. 2008. Cutting edge: Th1 cells facilitate the entry of Th17 cells to the central nervous system during experimental autoimmune encephalomyelitis. J. Immunol. 181: 3750-3754.
35. Jiang, H. R., M. Milovanović, D. Allan, W. Niedbala, A. G. Besnard, S. Y. Fukada, J. C. Alves-Filho, D. Togbe, C. S. Goodyear, C. Linington, et al. 2012. IL-33 attenuates EAE by suppressing IL-17 and IFN-γ production and inducing alternatively activated macrophages. Eur. J. Immunol. 42: 1804-1814.